Trial Outcomes & Findings for Health Literacy Intervention to Improve Diabetes Outcomes Among Rural Primary Care Patients (NCT NCT02779556)

NCT ID: NCT02779556

Last Updated: 2021-12-15

Results Overview

HbA1C will be obtained from patients' electronic health records, defined as the value closest to 6 months post baseline. The hemoglobin A1c (HbA1c) value ranges from approximately 4 to 14% where higher HbA1c value means worse outcome.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

756 participants

Primary outcome timeframe

Six months

Results posted on

2021-12-15

Participant Flow

Participant milestones

Participant milestones
Measure
Enhanced Usual Care
ADA Living Well with Diabetes Workbook, 15 minute in-person counseling, follow-up every 3 months ADA Living Well with Diabetes Workbook: American Diabetes Association (ADA) Living Well with Diabetes Workbook
Intervention
ACP Living with Diabetes Guide, 15 minute in-person counseling , 15 minute follow-up counseling (3, 6, and 9 months), monthly phone calls after 3 months ACP Living with Diabetes Guide: American Colleges of Physicians (ACP) Living Well with Diabetes Guide
Baseline
STARTED
394
362
Baseline
COMPLETED
393
362
Baseline
NOT COMPLETED
1
0
3 Months
STARTED
393
362
3 Months
COMPLETED
326
314
3 Months
NOT COMPLETED
67
48
6 Month
STARTED
353
333
6 Month
COMPLETED
320
294
6 Month
NOT COMPLETED
33
39
6 Month HbA1c
STARTED
394
362
6 Month HbA1c
COMPLETED
325
312
6 Month HbA1c
NOT COMPLETED
69
50
12 Month HbA1c
STARTED
394
362
12 Month HbA1c
COMPLETED
256
260
12 Month HbA1c
NOT COMPLETED
138
102

Reasons for withdrawal

Reasons for withdrawal
Measure
Enhanced Usual Care
ADA Living Well with Diabetes Workbook, 15 minute in-person counseling, follow-up every 3 months ADA Living Well with Diabetes Workbook: American Diabetes Association (ADA) Living Well with Diabetes Workbook
Intervention
ACP Living with Diabetes Guide, 15 minute in-person counseling , 15 minute follow-up counseling (3, 6, and 9 months), monthly phone calls after 3 months ACP Living with Diabetes Guide: American Colleges of Physicians (ACP) Living Well with Diabetes Guide
Baseline
Partial baseline interview completed
1
0
3 Months
Lost to Follow-up
40
29
3 Months
Missed 3 month clinic visit
27
19
6 Month
Lost to Follow-up
33
39
6 Month HbA1c
No value collected during window
69
50
12 Month HbA1c
No value collected during window
138
102

Baseline Characteristics

Health Literacy Intervention to Improve Diabetes Outcomes Among Rural Primary Care Patients

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Enhanced Usual Care
n=394 Participants
ADA Living Well with Diabetes Workbook, 15 minute in-person counseling, follow-up every 3 months ADA Living Well with Diabetes Workbook: American Diabetes Association (ADA) Living Well with Diabetes Workbook
Intervention
n=362 Participants
ACP Living with Diabetes Guide, 15 minute in-person counseling , 15 minute follow-up counseling (3, 6, and 9 months), monthly phone calls after 3 months ACP Living with Diabetes Guide: American Colleges of Physicians (ACP) Living Well with Diabetes Guide
Total
n=756 Participants
Total of all reporting groups
Age, Continuous
55.4 years
STANDARD_DEVIATION 11.8 • n=5 Participants
56.1 years
STANDARD_DEVIATION 11.4 • n=7 Participants
55.8 years
STANDARD_DEVIATION 11.7 • n=5 Participants
Sex: Female, Male
Female
275 Participants
n=5 Participants
235 Participants
n=7 Participants
510 Participants
n=5 Participants
Sex: Female, Male
Male
119 Participants
n=5 Participants
127 Participants
n=7 Participants
246 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
n=5 Participants
6 Participants
n=7 Participants
11 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
388 Participants
n=5 Participants
353 Participants
n=7 Participants
741 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
5 Participants
n=5 Participants
2 Participants
n=7 Participants
7 Participants
n=5 Participants
Race (NIH/OMB)
Asian
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
220 Participants
n=5 Participants
191 Participants
n=7 Participants
411 Participants
n=5 Participants
Race (NIH/OMB)
White
166 Participants
n=5 Participants
160 Participants
n=7 Participants
326 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=5 Participants
4 Participants
n=7 Participants
5 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
Education
Less than High School
87 Participants
n=5 Participants
66 Participants
n=7 Participants
153 Participants
n=5 Participants
Education
High School Graduate
141 Participants
n=5 Participants
127 Participants
n=7 Participants
268 Participants
n=5 Participants
Education
Some College
126 Participants
n=5 Participants
117 Participants
n=7 Participants
243 Participants
n=5 Participants
Education
College Graduate
40 Participants
n=5 Participants
50 Participants
n=7 Participants
90 Participants
n=5 Participants
Education
Refused to answer question
0 Participants
n=5 Participants
2 Participants
n=7 Participants
2 Participants
n=5 Participants
Health Literacy (NVS)
Limited
210 Participants
n=5 Participants
183 Participants
n=7 Participants
393 Participants
n=5 Participants
Health Literacy (NVS)
Adequate
184 Participants
n=5 Participants
179 Participants
n=7 Participants
363 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Six months

Population: 119 individuals were excluded from analysis, because they did not have a 6 month HbA1c value within the designated window.

HbA1C will be obtained from patients' electronic health records, defined as the value closest to 6 months post baseline. The hemoglobin A1c (HbA1c) value ranges from approximately 4 to 14% where higher HbA1c value means worse outcome.

Outcome measures

Outcome measures
Measure
Enhanced Usual Care
n=325 Participants
ADA Living Well with Diabetes Workbook, 15 minute in-person counseling, follow-up every 3 months ADA Living Well with Diabetes Workbook: American Diabetes Association (ADA) Living Well with Diabetes Workbook
Intervention
n=312 Participants
ACP Living with Diabetes Guide, 15 minute in-person counseling , 15 minute follow-up counseling (3, 6, and 9 months), monthly phone calls after 3 months ACP Living with Diabetes Guide: American Colleges of Physicians (ACP) Living Well with Diabetes Guide
Hemoglobin A1C (HbA1C)
8.4 Percentage of glycated hemoglobin
Interval 8.3 to 8.6
8.3 Percentage of glycated hemoglobin
Interval 8.1 to 8.5

PRIMARY outcome

Timeframe: Twelve months

Population: 240 individuals were excluded from analysis, because they did not have a 12 month HbA1c value within the designated window.

HbA1C will be obtained from patients' electronic health records, defined as the value closest to 12 months post baseline. The hemoglobin A1c (HbA1c) value ranges from approximately 4 to 14% where higher HbA1c value means worse outcome.

Outcome measures

Outcome measures
Measure
Enhanced Usual Care
n=260 Participants
ADA Living Well with Diabetes Workbook, 15 minute in-person counseling, follow-up every 3 months ADA Living Well with Diabetes Workbook: American Diabetes Association (ADA) Living Well with Diabetes Workbook
Intervention
n=256 Participants
ACP Living with Diabetes Guide, 15 minute in-person counseling , 15 minute follow-up counseling (3, 6, and 9 months), monthly phone calls after 3 months ACP Living with Diabetes Guide: American Colleges of Physicians (ACP) Living Well with Diabetes Guide
Hemoglobin A1C (HbA1C)
8.5 Percentage of glycated hemoglobin
Interval 8.3 to 8.7
8.4 Percentage of glycated hemoglobin
Interval 8.2 to 8.6

SECONDARY outcome

Timeframe: Three months

Population: 116 participants were excluded, missed 3 month visit.

A self-reported Diabetes Knowledge Questionnaire that uses 13 multiple choice questions will be administered. Total scores range from 0-13 where higher scores demonstrate more knowledge.

Outcome measures

Outcome measures
Measure
Enhanced Usual Care
n=326 Participants
ADA Living Well with Diabetes Workbook, 15 minute in-person counseling, follow-up every 3 months ADA Living Well with Diabetes Workbook: American Diabetes Association (ADA) Living Well with Diabetes Workbook
Intervention
n=314 Participants
ACP Living with Diabetes Guide, 15 minute in-person counseling , 15 minute follow-up counseling (3, 6, and 9 months), monthly phone calls after 3 months ACP Living with Diabetes Guide: American Colleges of Physicians (ACP) Living Well with Diabetes Guide
Diabetes Knowledge
9.2 Score on a scale
Interval 9.0 to 9.4
9.3 Score on a scale
Interval 9.1 to 9.5

SECONDARY outcome

Timeframe: Six months

Population: 142 participants were excluded, missed 6 month visit.

A self-reported Diabetes Knowledge Questionnaire that uses 13 multiple choice questions will be administered. Total scores range from 0-13 where higher scores demonstrate more knowledge.

Outcome measures

Outcome measures
Measure
Enhanced Usual Care
n=320 Participants
ADA Living Well with Diabetes Workbook, 15 minute in-person counseling, follow-up every 3 months ADA Living Well with Diabetes Workbook: American Diabetes Association (ADA) Living Well with Diabetes Workbook
Intervention
n=294 Participants
ACP Living with Diabetes Guide, 15 minute in-person counseling , 15 minute follow-up counseling (3, 6, and 9 months), monthly phone calls after 3 months ACP Living with Diabetes Guide: American Colleges of Physicians (ACP) Living Well with Diabetes Guide
Diabetes Knowledge (0-13)
9.5 Score on a scale
Interval 9.3 to 9.6
9.7 Score on a scale
Interval 9.5 to 9.9

Adverse Events

Enhanced Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 6 deaths

Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 3 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Kristie Hadden, PhD/Associate Professor

University of Arkansas for Medical Sciences

Phone: 501-993-3178

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place